Biological viability of the bone marrow stem cell cultured from bone disease patients
Biological viability of the bone marrow stem cell cultured from bone disease patients
批准号:
12671961
负责人:
YAMAZAKI Yasuharu
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The congenital cranio-maxillo-facial disorder is attributable to a lot of diseases and syndromes in the condition with abnormality of the head and the face. The Crouzon syndrome and the Apert syndrome, etc. are reported as abnormality of the FGFR gene family in that. However, even if it is the same disease, a clinical symptom is various from the serious to the slight stage, also it is true even if it is a congenital craniofacial disorder by the cause of same gene (FGFR2) as the phenotype.We thought that this depended on the change of a biological viability of the cell and the participation of a related gene.The change of a biological viability of the cell analyzed the bone marrow stem cell cultured from the cranio- maxillo-facial disorder patient.<Experimental method> B-FGF was administered to the osteoblasticlike cell from Apert syndrome patient. After having cultured that cell for a certain period, we measured both the viability of alkaline phosphatase (ALP) and the content of calciu … More m. The control used the cell from mandibular prognathism pateint. <Result> In the control group, alkaline phosphatase (ALP)'s viability and the content of calcium was inhibitory by the FGF administering. On the other hand, the inhibition by FGF was not observed in Apert syndrome patient's cell. This result suggests this possibility that the bone differentiation of the osteoblastic cell is not inhibited by FGF and the bone differentiation progressed compared with a healthy person, by the gene mutation of FGFR in the Apert syndrome patient. This was thought to be one of the generation causes of the craniosynostosis that was a clinical symptom of the apert syndrome.Moreover, in the participation of a related gene, the homeotic gene of hand between Apert syndrome patient and the control group were researched in genetic polymorphism.<Result>The possibility of the participation of a related gene was suggested in the Apert syndrome patient. It is scheduled to keep researching further- in the future. Informed consent is received from the patient based on the style permitted at this university ethics committee and the above-mentioned research is done. Less
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sakai N, Tokunaga K, Yamazaki Y, Shida H, Sakata Y, Susami T, Nakakita N, Takato T, Uchinuma E: "Sequence analysis of fibroblast growth factor receptor 2 (FGFR2) in Japanese patients with craniosynostosis"J Craniofac Surg. 12(6). 580-595 (2001)
Sakai N、Tokunaga K、Yamazaki Y、Shida H、Sakata Y、Susami T、Nakakita N、Takato T、Uchinuma E:“日本颅缝早闭患者成纤维细胞生长因子受体 2 (FGFR2) 的序列分析”J Craniofac Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大井田新一郎: "PCR-SSCP法による遺伝子診断"鶴見歯学. 26(3). 345-352 (2000)
Shinichiro Oida:“使用 PCR-SSCP 方法进行基因诊断”Tsurumi Dentistry 26(3) (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
宮島桜: "Hemifacial microsomiaの外科的矯正治療例"日本顎変形症学会雑誌. 10(3). 300-309 (2000)
Sakura Miyajima:“半面畸形的外科正畸治疗实例”日本颌畸形协会杂志 10(3) 300-309 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakai N: "A case of Japanese patient with cleidocranial dysplasia prossessing a mutation of CBFA1 gene"J Craniofac Surg. (in Press).
Sakai N:“一例患有 CBFA1 基因突变的日本锁骨颅骨发育不良患者”J Craniofac Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakai N, Hasegawa H, Yamazaki Y, Ui K, Tokunaga K, Hirose R, Uchinuma E, Susami T, Takato T: "A case of Japanese patient with cleidocranial dysplasia prossessing a mutation of CBFA1 gene"J Craniofac Surg. (in press).
Sakai N、Hasekawa H、Yamazaki Y、Ui K、Tokunaga K、Hirose R、Uchinuma E、Susami T、Takato T:“日本锁骨颅骨发育不良患者存在 CBFA1 基因突变”J Craniofac Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Possibility of bone substitute by using tissue engineering, concerning the bone grafting operation to the alveolar cleft of CL/CP.
-
批准号:23592942
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:YAMAZAKI Yasuharu
-
依托单位:
The cryopreservation of umbilical cord blood derived mesenchymal stem cells and the possibility of clinical application of those cells to cleft lip and palate patient.
-
批准号:20592345
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:YAMAZAKI Yasuharu
-
依托单位:
Quality and safety of cryopreserved human mesenchymal stem cell(MSC) during serial subculture
-
批准号:18592198
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.49万
-
财政年份:2006
-
负责人:YAMAZAKI Yasuharu
-
依托单位:
Development of a hybrid bone substitute with cryopreserved auto stem cell (human bone marrow derived mesenchymal stem cell)
-
批准号:16592018
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2004
-
负责人:YAMAZAKI Yasuharu
-
依托单位:
Epidemiological study and candidate gene analysis of cleft lip and /or plate in Japanese patients
-
批准号:10671903
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1998
-
负责人:YAMAZAKI Yasuharu
-
依托单位:
The Development of Bone Substitute Added with Bone Morphogenetic Protein and Clinical Application
-
批准号:01870086
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B).
-
资助金额:$1.92万
-
财政年份:1989
-
负责人:YAMAZAKI Yasuharu
-
依托单位:
海外基金